Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Feb 14, 2013 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0000315066-13-002557.pdf
0000315066-13-002557.rtf
Feb 14, 2013 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0000897204-13-000007.pdf
0000897204-13-000007.rtf
0000897204-13-000007.xls
Feb 14, 2013 5

Annual filing director officer or owner of more than ten percent.

View HTML
0000897204-13-000009.pdf
0000897204-13-000009.rtf
0000897204-13-000009.xls
Dec 21, 2012 10-Q/A

Amendment to a previously filed 10-Q

View HTML
0001144204-12-069143.pdf
0001144204-12-069143.rtf
0001144204-12-069143.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Dec 19, 2012 8-K

Report of unscheduled material events or corporate event

View HTML
0001144204-12-068593.pdf
0001144204-12-068593.rtf
0001144204-12-068593.xls
Nov 26, 2012 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001144204-12-064872.pdf
0001144204-12-064872.rtf
0001144204-12-064872.xls
Nov 26, 2012 CERTNAS

CERTNAS

View HTML
Nov 20, 2012 4

Statement of changes in beneficial ownership of securities

View HTML
0001144204-12-064351.pdf
0001144204-12-064351.rtf
Nov 20, 2012 4

Statement of changes in beneficial ownership of securities

View HTML
0001144204-12-064352.pdf
0001144204-12-064352.rtf
Nov 20, 2012 4

Statement of changes in beneficial ownership of securities

View HTML
0001144204-12-064355.pdf
0001144204-12-064355.rtf

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Current page 90
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT
© 2020 Intercept Pharmaceuticals, Inc.